FibroGen, Inc.
FGEN
$10.48
$0.131.26%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -50.78% | -12.66% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -50.78% | -12.66% | |||
| Cost of Revenue | -36.88% | 819.71% | |||
| Gross Profit | 31.19% | -416.82% | |||
| SG&A Expenses | -12.94% | -2.86% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -25.81% | 87.12% | |||
| Operating Income | 21.19% | -137.31% | |||
| Income Before Tax | 17.83% | -93.51% | |||
| Income Tax Expenses | -4,700.00% | 0.00% | |||
| Earnings from Continuing Operations | 18.39% | -93.49% | |||
| Earnings from Discontinued Operations | -71.60% | -19.67% | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -263.89% | -74.20% | |||
| EBIT | 21.19% | -137.31% | |||
| EBITDA | 20.94% | -145.95% | |||
| EPS Basic | -263.74% | -74.23% | |||
| Normalized Basic EPS | 19.65% | -114.06% | |||
| EPS Diluted | -263.74% | -74.23% | |||
| Normalized Diluted EPS | 19.65% | -114.06% | |||
| Average Basic Shares Outstanding | 0.09% | 0.12% | |||
| Average Diluted Shares Outstanding | 0.09% | 0.12% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||